Recognizing red flags in genetic cardiomyopathy: the importance of genetic testing.

Abstract excerpt

BACKGROUND: Despite the known genetic pathogenic variants involved in dilated cardiomyopathy (DCM), clinical practice often considers genetic testing as a secondary step rather than a diagnostic priority. In this report, we present a series of cases from our experience in Lebanon where the aggressive nature of specific genotypes, particularly Lamin A/C (LMNA) pathogenic genetic variants, was initially masked by...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Arrhythmias, Cardiac
• Share to Cardiomyopathy, Dilated
• Share to Disease Progression